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Abstract Ral-binding protein 1 (RalBPl) is a putative effector 
protein of Ral and possesses the GTPase-activating activity for 
Racl and CDC42. We examined the roles of the post-
translational modifications of Ral and Racl for the action of 
RalBPl. In COS cells, RalG23V, a constitutively active form, 
was mainly detected in the membrane fraction while most of 
RalG23V/C203S, a Ral mutant which is not post-translationally 
modified, was found in the cytosol fraction. When RalBPl was 
expressed alone in COS cells, it was found in the cytosol but not 
in the membrane fraction. When RalBPl was coexpressed with 
RalG23V, a part of RalBPl was found in the membrane fraction. 
However, when RalBPl was coexpressed with Ra]G23V/C203S5 an 
of RalBPl was recovered in the cytosol fraction. Although Ral 
bound to RalBPl at a molar ratio of 1:1, the interaction of Ral 
with RalBPl did not affect the GTPase-activating activity of 
RalBPl for Racl. Furthermore, RalBPl was more active on the 
post-translationally modified form of Racl and CDC42 than the 
unmodified form. These results suggest that the post-transla-
tional modification of Ral is important for the subcellular 
localization of RalBPl and that the interaction of Ral with 
RalBPl is not essential for the activity of RalBPl but plays a 
role in recruiting RalBPl to the membrane where its substrates, 
Racl and CDC42, reside. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Ral is a member of small G-protein superfamily and con-
sists of RalA and RalB [1]. As well as other small G proteins, 
Ral has the GDP-bound inactive and the GTP-bound active 
forms. The GDP-bound form of Ral is converted to the GTP-
bound form by RalGDS [2], and inversely the GTP-bound 
form is changed to the GDP-bound form by RalGAP [3]. 
We and other groups have found that RalGDS is a putative 
effector protein of Ras [4—6]. Since RalGDS stimulates the 
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GDP/GTP exchange of Ral [2], it is possible that there is a 
signaling pathway from Ras to Ral through RalGDS. Indeed, 
it has been shown that RalGDS stimulates the GDP/GTP 
exchange of Ral in a Ras-dependent manner in COS cells 
and that a dominant negative form of Ral blocks a Ras-de-
pendent transformation in NIH3T3 cells [7]. Furthermore, it 
has been demonstrated that RalGDS constitutes a Ras-signal-
ing pathway distinct from Raf and that RalGDS and Raf 
synergistically regulate cell proliferation and gene expression 
[8,9]. Thus, evidence has been accumulated that Ral and 
RalGDS act downstream of Ras and that Ral is an important 
small G protein in the intracellular signal transduction sys-
tem. However, the functions of Ral are not well known. 
One possible clue to clarify the functions of Ral is RalBPl 
which has been identified as a putative effector protein of Ral 
[10-12]. RalBPl contains a Ral-binding domain in its C-ter-
minal region and a RhoGAP homology domain in its central 
region. RalBPl exhibits the GAP activity for Racl and 
CDC42 but not for RhoA. Therefore, RalBPl may link be-
tween Ral and Racl or CDC42. However, the modes of acti-
vation and action of RalBPl are not clear since the studies 
using full-length RalBPl have not yet been done. 
The post-translational modifications of small G proteins are 
critical for their activation and action [13,14]. In a Ras/ 
RalGDS/Ral signaling pathway, we have shown that the 
post-translational modification of Ras is required for deter-
mining the subcellular localization of RalGDS and that the 
modification of Ral enhances the GDP/GTP exchange activity 
of RalGDS [15]. These results indicate that the post-transla-
tional modifications of Ras and Ral are important for the 
action of RalGDS. Therefore, we examined here the roles of 
the modifications of Ral and Racl in the action of RalBPl. 
2. Materials and methods 
2.1. Materials and chemicals 
The RalB, and Racl and CDC42 cDNAs were provided by Drs. R. 
Weinberg (Whitehead Institute for Biomedical Research, Cambridge, 
MA) and K. Kaibuchi (Nara Institute of Science and Technology, 
Ikoma, lapan), respectively. Baculoviruses expressing GST-RalB, 
GST-Racl, and GST-CDC42 were supplied from Dr. Y. Matsuura 
(National Institute of Health, Tokyo, Japan). The cDNA of RalBPl 
was isolated by reverse transcriptase PCR as described [15]. All pro-
cedures of passage, infection, and transfection of Sf9 cells and the 
isolation of baculoviruses were carried out as described [16]. MBP-
RalBPl, MBP-RalBPl-(364-647), GST-RalB, GST-Racl, and GST-
CDC42 were produced in and purified from E. coli in accordance 
with the manufacturer's instructions as described [15,17,18]. Small 
G proteins purified from E. coli were used as the post-translationally 
unmodified form. The post-translationally modified form of GST-
RalB was purified from the membrane fraction of Sf9 cell [15]. The 
post-translationally modified form of GST-Racl and GST-CDC42 
were purified from Sf9 cells by the use of Triton X-114 as described 
[19,20], Other materials and chemicals were from commercial sources. 
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2.2. Plasmid constructions 
pMAL/RalBPl-(364-647) (amino acid number 364-647), pV-IKS/ 
RalB, pV-IKS/Racl, pV-IKS/CDC42, pGEX2T/RalB, pGEX2T/ 
Racl, and pGEX2T/CDC42 were constructed as described 
[15,17,18]. To construct pCGN/RalBG23V (in which Gly-23 was 
changed to Val), pCGN/RalBS28N, and pCGN/RalBG23V/C203S, the 
0.6-kb fragments encoding RalBG23V, RalBS28N, and RalB
G23V/C203S 
with Xbal and BamHI sites were synthesized by PCR, and inserted 
into the Xbal and BamHI cut pCGN. To construct pBJ-Myc/RalBPl, 
pUC19/RalBPl [15] was digested with BamHI and the 1.9-kb frag-
ment encoding full-length RalBPl was inserted into the BamHI cut 
pBJ-Myc [18]. To construct pBJ-Myc/RalBPl-(l-415), pUC19/RalBPl 
was digested with BamHI and Bglil and the 1.2-kb fragment encoding 
RalBPl-(1-415) was inserted into the BamHI cut pBJ-Myc. To con-
struct pBJ-Myc/RalBPl-(364-647), pBSKS/RalBPl-(364-647) [15] was 
digested with BamHI and the 0.8-kb fragment encoding RalBPl-(364-
647) was inserted into the BamHI cut pBJ-Myc. To construct pMAL/ 
RalBPl, pUC19/RalBPl was digested with BamHI and the 1.9-kb 
fragment encoding full-length RalBPl was inserted into the BamHI 
cut pMAL-c2. 
2.3. Interaction of Ral with RalBPl in COS cells 
After COS cells (60-70% confluent on a 10-cm-diameter plate) were 
transfected with pCGN- and pBJ-derived constructs described above 
by the DEAE-dextran method [21], the cells were lysed as described 
[22]. The lysates expressing Ral with RalBPl were prepared and the 
proteins of the lysates (0.6 mg) were immunoprecipitated with the 
anti-Myc antibody and probed with the anti-Myc and HA antibodies 
[22,23]. To determine the subcellular localization of Ral and RalBPl, 
COS cells were fractionated into the cytosol and membrane fractions 
[15]. Aliquots (20 ug of protein) of the cytosol and membrane frac-
tions were probed with the anti-Myc and HA antibodies. 
2.4. Assay for the Ral-binding activity of RalBPl 
To make RalBPl or RalBPl-(364-647) immobilized on amylose 
resin, E. coli lysates (100 mg of protein) expressing MBP-RalBPl or 
MBP-RalBPl-(364-647) in lysis buffer (20 mM Tris-HCl (pH 7.5), 200 
mM NaCl, 1 mM DTT, 1 mM phenylmethylsulfonyl fluoride, 20 ug/ 
ml aprotinin, and 10 ug/ml leupeptin) were incubated with 200 ul of 
amylose resin for 2 h at 4°C. The resin was precipitated by centrifu-
gation and washed 3 times with 10 mM Tris-HCl (pH 7.5). One 
microlitre of the resin bound 0.6 pmol of MBP-RalBPl and 4.8 
pmol of MBP-RalBPl-(364-647). The [35S]GTPyS- or [3H]GDP-
bound form of GST-RalB was made as described [15] and incubated 
for 30 min at 4°C with immobilized RalBPl or RalBPl-(364-647) (4 
pmol of each) in 120 ul of reaction mixture (50 mM Tris-HCl (pH 
7.5), 20 mM MgCl?, 10 mM EDTA, 1 mM DTT, and 1 mg/ml BSA). 
After the immobilized RalBPl and RalBPl-(364-647) were precipi-
tated by centrifugation and washed, the remaining radioactivities 
were counted. During the procedures of this assay, neither [35S]GTPyS 
nor [3H]GDP was dissociated from GST-RalB. 
2.5. Assay for the GAP activity of RalBPl 
After the post-translationally modified or unmodified form of GST-
Racl and GST-CDC42 (4 pmol of each) were pre-incubated for 4 min 
at 30°C in 20 ul of the pre-incubation mixture (20 mM Tris-HCl (pH 
7.5), 2 uM [y-32P]GTP (4000-6000 cpm/pmol), 2 mM EDTA, 0.3% 
CHAPS, 1 mM L-a-dimyristoylphosphatidylcholine, 1 mM DTT, and 
40 mg/ml BSA), 4 ul of mixture (100 mM Tris-HCl (pH 7.5), 100 mM 
MgCl2, and 10 mM DTT) was added. To this pre-incubation mixture, 
16 ju.1 of reaction mixture (17.5 mM Tris-HCl (pH 7.5), 2.5 mM GTP, 
and 1 mM DTT) containing MBP-RalBPl was added, and the second 
incubation was performed with GST-Racl for 5 min at 25°C or with 
GST-CDC42 for 10 min at 25°C. Assays were quantified by rapid 
filtration on nitrocellulose filters. When the effect of the interaction 
of Ral with RalBPl on the GAP activity of RalBPl was examined, 
RalBPl immobilized on amylose resin was incubated with 1 uM 
GTPyS-bound post-translationally modified or unmodified form of 
Ral to make immobilized RalBPl interacting with Ral. The amylose 
resin was washed as described above and an aliquot was applied to 
SDS-polyacrylamide gel electrophoresis to estimate the amount of the 
immobilized proteins. The suspension of the amylose resin containing 
immobilized RalBPl or RalBPl interacting with Ral was used instead 
of RalBPl solution in the GAP assay for the post-translationally 
modified form of Racl. 
2.6. Other methods 
Protein concentrations were determined by the method of Lowry 
using BSA as a standard [24]. Triton X-114 phase separation assay of 
small G proteins was carried out as described [15,19]. 
3. Results 
3.1. Interaction of Ral with RalBPl in intact cells 
RalBPl has been identified as a putative effector protein of 
Ral, and in vitro and yeast two-hybrid experiments have 
shown that the C-terminal region of RalBPl interacts with 
Ral [10-12]. However, the studies in mammalian cells have 
not yet been done. Therefore, we first examined whether 
full-length RalBPl interacts with Ral in mammalian cells. 
RalBPl was coexpressed with RalG23V, a constitutively active 
form, or RalS28N, a dominant negative form, in COS cells 
(Fig. 1A, lanes 1^1). RalBPl was tagged with the Myc epitope 
at the N-terminus. RalG23V and RalS28N were tagged with the 
HA epitope at the N-terminus. When the lysates coexpressing 
RalG23V and RalBPl were immunoprecipitated with the anti-
Myc antibody, both RalG23V and RalBPl were detected in the 
RalBPl immune complex (Fig. 1A, lane 6). When the lysates 
expressing RalG23V alone were immunoprecipitated with the 
anti-Myc antibody, RalG23V was not detected (Fig. 1A, lane 
5). Neither RalG23V nor RalBPl was immunoprecipitated with 
non-immune immunoglobulin from the lysates expressing 
both proteins (data not shown). When RalBPl was coex-
pressed with RalS28N (Fig. 1A, lane 3), RalBPl did not 
make a complex with RalS28N (Fig. 1A, lane 7). These results 
indicate that RalBPl interacts with the GTP-bound form of 
Ral in intact mammalian cells. To exclude the possibility that 
the interaction of Ral with RalBPl in COS cells is non-specific 
due to overexpression of these proteins, we expressed RalG23V 
with RalBPl-(l-415) or RalBPl-(364-647). These RalBPl de-
letion mutants were tagged with the Myc epitope at the N-
terminus. The expression level of RalBPl-(l-415) was higher 
than that of RalBPl-(364-647) (Fig. IB, lanes 1 and 2). The 
expression levels of RalG23V were similar in these cells. 
RalG23V interacted with RalBPl-(364-647) but not with 
RalBPl-(l-415) (Fig. IB, lanes 3 and 4). These results indicate 
that the C-terminal region of RalBPl is necessary and suffi-
cient for its interaction with Ral in intact cells and that the 
interaction of Ral with RalBPl observed in Fig. 1A is not 
non-specific. 
3.2. Translocation of RalBPl by Ral in COS cells 
It has been reported that Ral is associated with the mem-
brane fractions such as plasma membranes, clathrin-coated 
vesicles, and secretory vesicles [1]. By analogy with other small 
G proteins, the post-translational modification of Ral at its C-
terminal cysteine could be important for its binding to the 
membrane [25]. Therefore, we examined the role of Ral in 
subcellular localization of RalBPl in intact cells. When 
RalG23V was expressed in COS cells, RalG23V appeared in 
both the cytosol and membrane fractions (Fig. 2A, lanes 3 
and 4). On the other hand, most of RaiG23V/C203S; a R a l m u_ 
tant which is not post-translationally modified, appeared in 
the cytosol fraction (Fig. 2A, lanes 5 and 6). When RalBPl 
was expressed alone in COS cells, it was detected in the cyto-
sol fraction (Fig. 2A, lanes 1 and 2). When RalBPl was coex-
pressed with RalG23V, a part of RalBPl was detected in the 
membrane fraction (Fig. 2A, lanes 3 and 4). Although the 
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Fig. 1. Interaction of Ral with RalBPl in mammalian cells. A: Interaction of Ral with RalBPl in COS cells. Aliquots of the lysates of COS 
cells expressing RalG23V alone (lane 1), both RalG23V and RalBPl (lane 2), or both RalS28N and RalBPl (lane 3) were probed with the anti-HA 
and Myc antibodies. COS cells transfected with the empty vectors were control (lane 4). The lysates of COS cells expressing RalG23V alone 
(lane 5), both RalG23V and RalBPl (lane 6), or both RalS28N and RalBPl (lane 7) were immunoprecipitated with the anti-Myc antibody. The 
precipitates were probed with the anti-Myc and HA antibodies. B: Interaction of Ral with RalBPl-(364-647) in COS cells. The lysates of COS 
cells expressing both RalG23V and RalBPl-(l-415) (lanes 1 and 3) or both RalG23V and RalBPl-(364-647) (lanes 2 and 4) were directly probed 
with the anti-Myc and HA antibodies (lanes 1 and 2) or immunoprecipitated with the anti-Myc antibody, then probed with the anti-Myc and 
HA antibodies (lanes 3 and 4). Arrowheads indicate the positions of RalBPl, RalBPl-(l-415), and RalBPl-(364-647). Arrows indicate the posi-
tions of RalG23V and RalS28N. IP, immunoprecipitation; Ig, immunoglobulin; Ab, antibody. The results shown are representative of three inde-
pendent experiments. 
amount of RalBPl in the membrane fraction appeared to be 
small, this result was reproducible. However, when RalBPl 
was coexpressed with Ral
G23V/C203S, RalBPl was found in 
the cytosol fraction but not in the membrane fraction (Fig. 
2A, lanes 5 and 6). These observations were confirmed using 
RalBPl-(364-647) (Fig. 2B). When RalBPl-(364-647) was ex-
pressed alone in COS cells, it was found in the cytosol frac-
tion. When RalBPl-(364-647) was coexpressed with RalG23V, 
RalBPl-(364-647) was found in both the cytosol and mem-
brane fractions, while when RalBPl-(364-647) was coex-
pressed with RaiG23V/C203S; RalBPl-(364-647) was found in 
the cytosol fraction. These results suggest that Ral localized 
on the membrane recruits RalBPl from the cytosol to the 
membrane. 
3A). Previously we have shown that the post-translational 
modification of Ral increases its affinity for RalBPl [15]. 
Under the conditions that the post-translationally modified 
or unmodified form of Ral bound to RalBPl stoichiometri-
cally, we measured the GAP activity of RalBPl for Racl. In 
this experiment we used RalBPl immobilized on amylose resin 
as a source of GAP and the post-translationally modified 
form of Racl as a substrate. The GAP activity of immobilized 
RalBPl was attenuated as compared with that of soluble 
RalBPl (compare Fig. 3B with Fig. 4A). RalBPl interacting 
with the modified or unmodified form of Ral exhibited the 
same GAP activity as RalBPl itself (Fig. 3B). These results 
indicate that the interaction of Ral with RalBPl does not 
affect the GAP activity of RalBPl. 
3.3. Effect of the interaction of Ral with RalBPl on the GAP 
activity of RalBPl 
It has been demonstrated that the Ral-binding domain of 
RalBPl is not necessary for the GAP activity [10]. Therefore, 
we examined whether the interaction of Ral with RalBPl 
affected the GAP activity of RalBPl. Since the Ral-binding 
activity of RalBPl using full-length RalBPl had not yet been 
biochemically characterized, we measured its K& and Bmax. 
RalBPl interacted with the GTPyS-, but not with the GDP-, 
bound form of Ral in a dose-dependent manner (Fig. 3A). 
Scatchard plot analysis revealed that RalBPl bound to Ral 
at a molar ratio of 1:0.9 with a K& value of 230 nM. The Ral-
binding activity of RalBPl-(364-647) was similar to that of 
full-length RalBPl, and this deletion mutant bound to Ral 
at a molar ratio of 1:0.8 with a K& value of 200 nM (Fig. 
3.4. Effect of the post-translational modifications of Racl and 
CDC42 on the GAP activity of RalBPl 
Finally we examined the effect of the post-translational 
modifications of small G proteins on the GAP activity of 
RalBPl. We confirmed that GST-Racl and GST-CDC42 pu-
rified from Sf9 cells are post-translationally modified and 
those from E. coli are post-translationally unmodified by the 
Triton X-114 phase separation method (data not shown). 
GTP was hydrolyzed in both the modified and unmodified 
forms of these small G proteins with the similar efficiency 
(data not shown). Consistent with previous observations, 
RalBPl stimulated the GTPase activity of the post-transla-
tionally unmodified form of Racl and CDC42 (Fig. 4A,B). 
RalBPl was more active on the post-translationally modified 
form of Racl and CDC42 than the unmodified form (Fig. 
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Fig. 2. Translocation of RalBPl by Ral. A: Translocation of RalBPl by RalG23V but not by Ral
G23V/C203S. COS cells expressing RalBPl alone 
(lanes 1 and 2), both RalG23V and RalBPl (lanes 3 and 4), or both Ra]
G23V/C203S and RalBPl (lanes 5 and 6) were disrupted and separated 
into the cytosol (lanes 1, 3, and 5) and membrane (lanes 2, 4, and 6) fractions. Aliquots of each sample were probed with the anti-Myc and 
HA antibodies. B: Translocation of RalBPl-(364-647) by RalG23V. COS cells expressing RalBPl-(364-647) alone (lanes 1 and 2), both RalG23V 
and RalBPl-(364-647) (lanes 3 and 4), or both RalG23V/C203S a n d RalBPl-(364-647) (lanes 5 and 6) were disrupted and separated into the cyto-
sol (lanes 1, 3, and 5) and membrane (lanes 2, 4, and 6) fractions. Aliquots of each sample were probed with the anti-Myc and HA antibodies. 
C, cytosol fraction; M, membrane fraction; Ab, antibody. Arrowheads indicate the positions of RalBPl and RalBPl-(364-647). Arrows indicate 
the positions of RalG23V and Ral
G23V/C203S j n e r e s u i t s shown are representative of three independent experiments. 
Ral (|iM) 
0.2 0.4 
RalBPl (|iM) 
Fig. 3. Effect of the interaction of Ral with RalBPl on the GAP activity of RalBPl. A: Interaction of Ral with RalBPl in vitro. RalBPl(«) 
or RalBPl-(364-647) (■) immobilized on amylose resin (4 pmol of each) was incubated with the indicated concentrations of the [35S]GTPyS-
(—-) or [3H]GDP- ( ) bound post-translationally unmodified form of GST-RalB. After the samples were precipitated by centrifugation, 
the remaining radioactivities were counted. B: The GAP activity of RalBPl. The [y-32P]GTP-bound post-translationally modified form of GST-
Racl (4 pmol) was incubated for 5 min at 25°C with the indicated concentrations of immobilized RalBPl (■) or immobilized RalBPl stoichio-
metrically interacting with the GTPyS-bound modified (•) or unmodified (o) form of GST-RalB. The results shown are representative of four 
independent experiments. 
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RalBPl (fxM) 
0.5 
RalBPl (nM) 
Fig. 4. Effect of the post-translational modifications of small G proteins on the GAP activity of RalBPl. The GAP activities of the indicated 
concentrations of RalBPl for the post-translationally modified (•) and unmodified (o) forms of GST-Racl or GST-CDC42 (4 pmol of each) 
were assayed. A: Racl. B: CDC42. The results shown are representative of three independent experiments. 
4A,B). These results indicate that the post-translational mod-
ifications of Racl and CDC42 enhance the GAP activity of 
RalBPl. 
4. Discussion 
RalBPl has been identified as a putative effector protein of 
Ral and shown to possess the GAP activity for Racl and 
CDC42 [10-12]. However, it has not yet been shown that 
RalBPl interacts with Ral in intact cells. We have demon-
strated for the first time that full-length RalBPl binds to an 
active form of Ral but not to a dominant negative form of 
Ral in COS cells. Furthermore, we have shown that RalBPl 
stoichiometrically binds to the GTPyS-bound form of Ral 
with a Kd value of 230 nM. These results strongly support 
the possibility that RalBPl is an effector protein of Ral. We 
have also demonstrated that the interaction of Ral with 
RalBPl does not affect the GAP activity of RalBPl for 
Racl under the condition that RalBPl binds to Ral stoichio-
metrically. Taken together with the previous observation that 
the Ral-binding domain of RalBPl is not necessary for its 
GAP activity [10], these results suggest that Ral does not serve 
as an allosteric regulator of RalBPl and that there is some 
mechanism by which Ral influences the functions of Racl and 
CDC42 in cells. 
Many signal transduction molecules translocate to the 
membrane. Ras resides on the plasma membrane through its 
post-translational modification [13,14,26]. Raf is an important 
Ras effector protein and usually present in the cytosol. When 
Ras is activated, Raf translocates from the cytosol to the 
membrane by binding to Ras and is activated to transmit 
the signal to mitogen activated protein kinase cascade [27]. 
Raf which has a membrane-localizing motif is constitutively 
activated without the Ras activation [28,29]. Thus, a role of 
Ras in the activation of Raf could be to recruit Raf to the 
membrane. Consistent with these observations, our results 
have shown that Ral localized on the membrane induces the 
translocation of RalBPl from the cytosol to the membrane. 
Ral is present not only in the plasma membrane along with 
Ras but also in the intracellular vesicles [1]. Rac and CDC42 
interact with the membrane and cytoskeleton [30,31] and reg-
ulate cell shape and motility [32-34]. Recently Rac has been 
shown to regulate receptor-mediated endocytosis, especially 
clathrin-coated vesicle formation [35]. These results suggest 
that Rac is also present in the intracellular vesicles. Therefore, 
RalBPl may act as a negative regulator for Racl and CDC42 
when these small G proteins are colocalized with Ral on the 
same sites. Inversely, when RalBPl translocates to the mem-
brane where Racl and CDC42 are not present, Ral may po-
tentiate the activities of Racl and CDC42 by removing 
RalBPl from a compartment in which it serves as a GAP 
for Racl and CDC42. However, since our experiments have 
been done by overexpression of RalBPl and/or Ral in COS 
cells, we cannot exclude the possibility that endogenous 
RalBPl is localized on the membrane, that overexpressed 
RalBPl is in the cytosol simply because RalBPl is already 
saturated on the membrane, and that addition of RalG23V 
takes this excess of RalBPl to the membrane. Therefore, it 
is necessary to determine subcellular localization of endoge-
nous Ral and RalBPl by their specific antibodies. 
It has been known that the post-translational modifications 
of small G proteins are critical for their functions and the 
actions of their GDP/GTP exchange proteins [14,26]. In con-
trast to GDP/GTP exchange proteins, the post-translational 
modifications of small G proteins do not affect the activity of 
RasGAP, RapGAP, or RalGAP [15,36,37]. However, we have 
shown that the post-translational modifications of Racl and 
CDC42 enhance the GAP activity of RalBPl. Recently Rab3-
GAP has been purified from rat brain and found to be active 
on the post-translationally modified form of Rab3A but not 
on the unmodified from [38]. Thus, the roles of the post-trans-
lational modifications of small G proteins in the GAP action 
vary depending on GAP types. Taken together with our pre-
vious observations that the post-translational modification of 
Ras is necessary for the translocation of RalGDS and that the 
modification of Ral enhances the action of RalGDS [15], it is 
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conceivable that the modifications of Ras , Ral, and Rac l play 
a role not only for their subcellular localization but also for 
transmitting the signals effectively on the membranes in the 
signaling pathway of Ras /Ra lGDS/Ral /Ra lBPl /Rac l . 
The G A P activity of RalBPl for Rac l and CDC42 is rather 
weak as compared with those of other R h o G A P family mem-
bers. It is known that Raf, Rabphilin-3A, and phospholipase 
C-P are the effector proteins of Ras , Rab3A, and Gq, respec-
tively, and that they have the weak G A P activities for these 
G proteins [39—41]. Furthermore, it has been shown that 
Ra lBPl interacts with Rac l in yeast two-hybrid experiment 
[11]. These results suggest that RalBPl may act as an effector 
protein rather than serve as a negative regulator of Rac l and 
CDC42. In addition to the R h o G A P homology domain, 
Ra lBPl has two oc-helix regions [10,11]. These regions may 
associate with other molecules which induce downstream 
events. Fur ther studies are necessary to understand the whole 
picture of the physiological roles of the Ra l -Ra lBP l pathway 
in the intracellular signal transduction system and cellular 
functions. 
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